Druart, L.;                     Graham Longsworth, S.;                     Rolland, C.;                     Dolgopoloff, M.;                     Terrisse, H.;                     Bosson, J.-L.;                     Pinsault, N.    
        Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol. Medicines 2020, 7, 3.
    https://doi.org/10.3390/medicines7010003
    AMA Style
    
                                Druart L,                                 Graham Longsworth S,                                 Rolland C,                                 Dolgopoloff M,                                 Terrisse H,                                 Bosson J-L,                                 Pinsault N.        
                Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol. Medicines. 2020; 7(1):3.
        https://doi.org/10.3390/medicines7010003
    
    Chicago/Turabian Style
    
                                Druart, Leo,                                 SaraEve Graham Longsworth,                                 Carole Rolland,                                 Maïa Dolgopoloff,                                 Hugo Terrisse,                                 Jean-Luc Bosson,                                 and Nicolas Pinsault.        
                2020. "Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol" Medicines 7, no. 1: 3.
        https://doi.org/10.3390/medicines7010003
    
    APA Style
    
                                Druart, L.,                                 Graham Longsworth, S.,                                 Rolland, C.,                                 Dolgopoloff, M.,                                 Terrisse, H.,                                 Bosson, J.-L.,                                 & Pinsault, N.        
        
        (2020). Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol. Medicines, 7(1), 3.
        https://doi.org/10.3390/medicines7010003